Xact Robotics Appoints VP of Sales and Marketing

Following the recent FDA clearance of its Xact Robotic System and the completion of its latest financial round totaling $36M, Xact Robotics Ltd. has appointed Brian L. Allen as vice president of Sales and Marketing. A proven commercial executive in medical robotics, Allen brings more than two decades of MedTech leadership delivering medical device technologies including, amongst others, the launch of Mako Surgical Corp. robotic system.
 
“We’re excited to have Brian lead our accelerated commercialization focus and efforts,” commented Harel Gadot, executive chairman and president, Xact Robotics. “Brian’s medical robotics pedigree, proven leadership in building successful provider and healthcare system partnerships, and track record of scaling numerous MedTech disruptors, will prove invaluable as we establish Xact Robotics as the global leader in medical robotics.”
 
Allen recently served as senior vice president of Business Development for HeartSciences, where he led the global market release of a wavelet signal processed electrocardiogram with AI machine learning. Previously, Allen served as vice president of Sales and Commercial Marketing for OrthoSensor Inc., where he launched a sensor-assisted instrument for total knee replacement surgery. Most notably, Brian served as the director of Sales and Marketing for Mako Surgical Corp., establishing its to-market strategy, building and leading its commercial team and scaling its year-over-year revenue, resulting in its acquisition by Stryker for $1.65 billion. Allen holds a Bachelor of Arts (BA) from Western Michigan University as well as executive education from the Sloan School of Management at the Massachusetts Institute of Technology.
 
“I am excited to dive into this unique opportunity, and join Xact Robotics at this pivotal time as we redefine what the future of medical robotics should become with the first hands-free robotic system,” said Allen. “I look forward to bringing the XACT Robotic System to market, a technology that will no doubt empower providers to realize a higher clinical, technical and economic potential while restoring health and improving the quality of life for the patients they serve.”